Insider · CIK 0001361896
Justin W Yorke
Files at PCSA (Processa Pharmaceuticals, Inc.), EDVA (SPLASH BEVERAGE GROUP, INC.). First filing -, latest -.
In brief
Justin W Yorke files SEC Form 4 as director at PCSA (Processa Pharmaceuticals, Inc.), and also at EDVA (SPLASH BEVERAGE GROUP, INC.). No open-market trade is on file; the transactions below are grants, exercises and other rows that carry no view on the price.
A track record needs three past buys with six months of prices behind them; Justin W Yorke has 0, so none is measured yet.
Signals
This insider’s open-market buys and sells, scored.
Transactions
Every row this insider has filed, 10 in all, newest first.
| Date | Company | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Jul 26, 2026 | PCSA Processa Pharmaceuticals, Inc. | AGrant or award Restricted Stock Unitsderivative | +33,500 | $0.00 | $0 | 38,749 | Jul 28, 2026 |
| Jun 26, 2026 | PCSA Processa Pharmaceuticals, Inc. | MOption exercise Common Stock | +203 | - | - | 353 | Jun 30, 2026 |
| Jun 26, 2026 | PCSA Processa Pharmaceuticals, Inc. | MOption exercise Restricted Stockderivative | -203 | $0.00 | $0 | 5,249 | Jun 30, 2026 |
| Jul 31, 2025 | EDVA SPLASH BEVERAGE GROUP, INC. | AGrant or award Warrantsderivative | +750,000 | - | - | 750,000 | Oct 15, 2025 |
| Oct 1, 2025 | PCSA Processa Pharmaceuticals, Inc. | AGrant or award Restricted Stock Unitsderivative | +100,000 | $0.00 | $0 | 100,000 | Oct 3, 2025 |
| Oct 1, 2025 | PCSA Processa Pharmaceuticals, Inc. | AGrant or award Stock Options (Right to Buy)derivative | +300,000 | $0.00 | $0 | 300,000 | Oct 3, 2025 |
| Jul 24, 2025 | PCSA Processa Pharmaceuticals, Inc. | AGrant or award Restricted Stockderivative | +175,299 | $0.00 | $0 | 206,505 | Jul 28, 2025 |
| Nov 21, 2023 | PCSA Processa Pharmaceuticals, Inc. | JOther Common Stockindirect: By Richland Fund, LLC | -55,267 | $0.00 | $0 | 464,623 | Nov 28, 2023 |
| Oct 12, 2023 | PCSA Processa Pharmaceuticals, Inc. | AGrant or award Common Stock | +6,000 | $0.30 | $1,800 | 74,729 | Oct 23, 2023 |
| Oct 12, 2023 | PCSA Processa Pharmaceuticals, Inc. | AGrant or award Common Stock | +6,000 | $0.30 | $1,800 | 75,729 | Oct 12, 2023 |
Questions about Justin W Yorke
Answered from the filings on this page, as of the latest one.
Is Justin W Yorke buying or selling?
Justin W Yorke has no open-market buy or sell on SEC Form 4; the filings on record are grants, exercises and other transactions.
How did Justin W Yorke's past buys perform?
Not measured yet. InsiderTell needs three past buys with six months of prices to publish a track record, and Justin W Yorke has 0.
Where does Justin W Yorke file Form 4?
Justin W Yorke has filed Form 4 at PCSA (Processa Pharmaceuticals, Inc.); EDVA (SPLASH BEVERAGE GROUP, INC.). A Form 4 is required of officers, directors and holders of more than 10% of a share class within two business days of a trade.
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.